Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 1.12
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Iconovo AB (publ) develops and licenses inhalation devices in Sweden. It develops ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler, as well as provides customized inhalation solutions. It serves generic companies. The company has an...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers.
Data is available to registered users only
Target Price
The average target price of ICO.ST is 1.1 and suggests 6% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec
Data is available to registered users only
Buy
Sell